Apotential role for α-actinin in inside-out αIIbβ3 signaling

Blood

Volumn 117, Issue 1, 2011, Pages 250-258

  Tadokoro, Seiji ^a   Nakazawa, Tsuyoshi ^a   Kamae, Tsuyoshi ^a   Kiyomizu, Kazunobu ^a   Kashiwagi, Hirokazu ^a   Honda, Shigenori ^c   Kanakura, Yuzuru ^a   Tomiyama, Yoshiaki ^a,b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY HOSPITAL   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ; ALPHAIIBBETA3 INTEGRIN; DUAL SPECIFICITY PHOSPHATASE 2; INTEGRIN; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 4; UNCLASSIFIED DRUG; ACTININ; FIBRINOGEN RECEPTOR; MESSENGER RNA; P2RY12 PROTEIN, HUMAN; PROTEINASE ACTIVATED RECEPTOR 2; PURINERGIC P2Y12 RECEPTOR; TYROSINE;

ARTICLE; CELL LINE; CONTROLLED STUDY; DISSOCIATION; ENZYME BINDING; HUMAN; HUMAN CELL; LIGAND BINDING; MEGAKARYOBLAST; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; THROMBOCYTE; TIME; VELOCITY; ACUTE MEGAKARYOCYTIC LEUKEMIA; FLOW CYTOMETRY; GENETICS; GLANZMANN DISEASE; IMMUNOPRECIPITATION; METABOLISM; PATHOLOGY; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE AGGREGATION; TUMOR CELL CULTURE; WESTERN BLOTTING;

ACTININ; BLOOD PLATELETS; BLOTTING, WESTERN; FLOW CYTOMETRY; HUMANS; IMMUNOPRECIPITATION; LEUKEMIA, MEGAKARYOBLASTIC, ACUTE; PHOSPHORYLATION; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECEPTOR, PAR-1; RECEPTOR, PAR-2; RECEPTORS, PURINERGIC P2Y12; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THROMBASTHENIA; TUMOR CELLS, CULTURED; TYROSINE;

EID: 78650970167     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-10-246751     Document Type: Article

References (45)

1. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110(6):673-687.
2. Shattil SJ, Newman PJ. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood. 2004;104(6):1606-1615. (Pubitemid 39202265)
3. O'Toole TE, Katagiri Y, Faull RJ, et al. Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol. 1994;124(6):1047-1059.
4. Tadokoro S, Shattil SJ, Eto K, et al. Talin binding to integrin beta tails: a final common step in integrin activation. Science. 2003;302(5642):103- 106. (Pubitemid 37210697)
5. Moser M, Legate KR, Zent R, Fässler R. The tail of integrins, talin, and kindlins. Science. 2009; 324(5929):895-899.
6. Wegener KL, Partridge AW, Han J, et al. Structural basis of integrin activation by talin. Cell. 2007;128(1):171-182. (Pubitemid 46048890)
7. Petrich BG, Marchese P, Ruggeri ZM, et al. Talin is required for integrin-mediated platelet function in hemostasis and thrombosis. J Exp Med. 2007; 204(13):3103-3111.
8. Nieswandt B, Moser M, Pleines I, et al. Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo. J Exp Med. 2007;204(13):3113-3118.
9. Moser M, Nieswandt B, Ussar S, Pozgajova M, Fässler R. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat Med. 2008; 14(3):325-330. (Pubitemid 351347914)
10. Ma YQ, Qin J, Wu C, Plow EF. Kindlin-2 (Mig-2): a co-activator of beta3 integrins. J Cell Biol. 2008; 181(3):439-446.
11. Harburger DS, Bouaouina M, Calderwood DA. Kindlin-1 and -2 directly bind the C-terminal region of beta integrin cytoplasmic tails and exert integrin-specific activation effects. J Biol Chem. 2009;284(17):11485-11497.
12. Kiema T, Lad Y, Jiang P, et al. The molecular basis of filamin binding to integrins and competition with talin. Mol Cell. 2006;21(3):337-347.
13. Otey CA, Carpen O. alpha-Actinin revisited: a fresh look at an old player. Cell Motil Cytoskeleton. 2004;58(2):104-111.
14. Sjöblom B, Salmazo A, Djinović-Carugo K. alpha-Actinin structure and regulation. Cell Mol Life Sci. 2008;65(17):2688-2701.
15. Otey CA, Pavalko FM, Burridge K. An interaction between alpha-actinin and the beta1 integrin subunit in vitro. J Cell Biol. 1990;111(2):721-729.
16. Pavalko FM, LaRoche SM. Activation of human neutrophils induces an interaction between the integrin beta2-subunit (CD18) and the actin binding protein alpha-actinin. J Immunol. 1993;151(7):3795-3807.
17. Smith A, Carrasco YR, Stanley P, Kieffer N, Batista FD, Hogg N. A talin-dependent LFA-1 focal zone is formed by rapidly migrating T lymphocytes. J Cell Biol. 2005;170(1):141-151. (Pubitemid 40994103)
18. Stanley P, Smith A, McDowall A, Nicol A, Zicha D, Hogg N. Intermediate-affinity LFA-1 binds alpha-actinin-1 to control migration at the leading edge of the T cell. EMBO J. 2008;27(1):62-75.
19. Shattil SJ, Ginsberg MH, Brugge JS. Adhesive signaling in platelets. Curr Opin Cell Biol. 1994; 6(5):695-704.
20. Haimovich B, Lipfert L, Brugge JS, Shattil SJ. Tyrosine phosphorylation and cytoskeletal reorganization in platelets are triggered by interaction of integrin receptors with their immobilized ligands. J Biol Chem. 1993;268(21):15868-15877.
21. Izaguirre G, Aguirre L, Ji P, Aneskievich B, Haimovich B. Tyrosine phosphorylation of alpha-actinin in activated platelets. J Biol Chem. 1999;274(52):37012-37020.
22. Izaguirre G, Aguirre L, Hu YP, et al. The cytoskeletal/ non-muscle isoform of alpha-actinin is phosphorylated on its actin-binding domain by the focal adhesion kinase. J Biol Chem. 2001;276(31):28676-28685.
23. Lin SY, Raval S, Zhang Z, et al. The proteintyrosine phosphatase SHP-1 regulates the phosphorylation of alpha-actinin. J Biol Chem. 2004; 279(24):25755-25764. (Pubitemid 38756839)
24. Shiraga M, Miyata S, Kato H, et al. Impaired platelet function in a patient with P2Y12 deficiency caused by a mutation in the translation initiation codon. J Thromb Haemost. 2005;3(10):2315-2323. (Pubitemid 41727212)
25. Tokuhira M, Handa M, Kamata T, et al. A novel regulatory epitope defined by a murine monoclonal antibody to the platelet GPIIb-IIIa complex (alphaIIbbeta3 integrin). Thromb Haemost. 1996; 76(6):1038-1046.
26. 2+ signaling. Blood. 1998;92(10): 3675-3683.
27. Kashiwagi H, Shiraga M, Honda S, et al. Activation of integrin alphaIIbbeta3 in the glycoprotein Ib-high population of a megakaryocytic cell line, CMK, by inside-out signaling. J Thromb Haemost. 2004;2(1):177-186. (Pubitemid 40185635)
28. LaFlamme SE, Akiyama SK, Yamada KM. Regulation of fibronectin receptor distribution. J Cell Biol. 1992;117(2):437-447.
29. Kamae T, Shiraga M, Kashiwagi H, et al. Critical role of ADP interaction with P2Y12 receptor in the maintenance of alphaIIbbeta3 activation: association with Rap1B activation. J Thromb Haemost. 2006;4(6):1379-1387.
30. Shiraga M, Kamae T, Akiyama M, et al. P2Y12-independent transient activation and P2Y12-dependent prolonged activation of platelet integrin alphaIIbbeta3 [abstract]. Blood. 2006;108(11):435a. Abstract 1509.
31. Arabaci G, Guo XC, Beebe KD, Coggeshall KM, Pei D. alpha-Haloacetophenone derivatives as photoreversible covalent inhibitors of protein tyrosine phosphatases. J Am Chem Soc. 1999; 121(21):5085-5086. (Pubitemid 29269148)
32. Aleil B, Ravanat C, Cazenave JP, Rochoux G, Heitz A, Gachet C. Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost. 2005;3(1):85-92. (Pubitemid 41647119)
33. Kahn ML, Zheng YW, Huang W, et al. A dual thrombin receptor system for platelet activation. Nature. 1998;394(6694):690-694. (Pubitemid 28389797)
34. Covic L, Gresser AL, Kuliopulos A. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Biochemistry. 2000;39(18):5458-5467. (Pubitemid 30257087)
35. Shapiro MJ, Weiss EJ, Faruqi TR, Coughlin SR. Protease activated receptor 1 and 4 are shut off with distinct kinetics after activation by thrombin. J Biol Chem. 2000;275(33):25216-25221.
36. Frojmovic M, Wong T, van de Ven T. Dynamic measurements of the platelet membrane glycoprotein IIb-IIIa receptor for fibrinogen by flow cytometry, I: methodology, theory and results for two distinct activators. Biophys J. 1991;59(4):815-827.
37. O'Toole TE, Loftus JC, Du XP, et al. Affinity modulation of the alphaIIbbeta3 integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor. Cell Regul. 1990;1(12):883-893.
38. Legate KR, Fässler R. Mechanisms that regulate adaptor binding to beta-integrin cytoplasmic tails. J Cell Sci. 2009;122(Pt 2):187-198.
39. Ye F, Hu G, Taylor D, et al. Recreation of the terminal events in physiological integrin activation. J Cell Biol. 2010;188(1):157-173.
40. Lau TL, Kim C, Ginsberg MH, Ulmer TS. The structure of the integrin alphaIIbbeta3 transmembrane complex explains integrin transmembrane signalling. EMBO J. 2009;28(9):1351-1361.
41. Lyman S, Gilmore A, Burridge K, Gidwitz S, White GCII. Integrin-mediated activation of focal adhesion kinase is independent of focal adhesion formation or integrin activation. Studies with activated and inhibitory beta3 cytoplasmic domain mutants. J Biol Chem. 1997;272(36):22538-22547.
42. von Wichert G, Haimovich B, Feng GS, Sheetz MP. Force-dependent integrin-cytoskeleton linkage formation requires downregulation of focal complex dynamics by Shp2. EMBO J. 2003;22(19):5023-5035. (Pubitemid 37222023)
43. Feng S, Lu X, Reséndiz JC, Kroll MH. Pathological shear stress directly regulates platelet alphaIIbbeta3 signaling. Am J Physiol Cell Physiol. 2006;291(6):C1346-C1354.
44. Tomiyama Y, Shiraga M, Kashiwagi H. Positive and negative regulation of integrin function. In: Tanaka K, Davie EW, eds. Recent Advances in Thrombosis and Hemostasis 2008. New York, NY: Springer;2008:243-252.
45. Brass LF, Zhu L, Stalker TJ. Minding the gaps to promote thrombus growth and stability. J Clin Invest. 2005;115(12):3385-3392.